Fabrication and characterization of hybrid coating on Mg–Zn–Ca Mg alloy for enhanced corrosion and degradation resistance as medical implant. Issue 16 (15th August 2022)

• Record Type: Journal Article
• Authors: Rahman, Mostafizur; Chowdhury, Mohammad Asaduzzaman; Mia, Md. Shahin; Ali, Md. Ramjan; Rahman, Atiqur; Ali, Md. Osman; Mahmud, Saifullah
• Is Part Of: Ceramics international. Volume 48:Issue 16(2022)
• Page Start: 23314
• Page End: 23324
• Publication Date: 2022-08-15
• Subjects: Magnesium -- Nanocomposite -- Degradation -- Corrosion -- Cytotoxicity -- Biocompatibility; Ceramics -- Periodicals; Céramique industrielle -- Périodiques; Ceramics; Periodicals; Electronic journals; 666
• DOI: 10.1016/j.ceramint.2022.04.319
• Languages: English
• ISSNs: 0272-8842

Abstract

Abstract: Magnesium (Mg)-based alloys have appealing properties as promising implants for medical applications. However, their clinical applications are hindered due to the rapid corrosion and degradation rate in the physiological environment. In this investigation, we reported a novel interfacial engineering approach for the fabrication of polymer/ceramic hybrid coating on Mg–Zn–Ca Mg alloy. Firstly, hydroxyapatite (HA) coating was fabricated on the Mg–Zn–Ca sample followed by an alkali treatment that was performed in 1 M NaOH solution at 60 °C. Finally, polycaprolactone (PCL) coating was synthesized using a dip-coating approach on the top of the HA-coated Mg–Zn–Ca specimen. Microhardness test and adhesion test revealed that PCL/HA hybrid coating significantly improved mechanical properties and enhanced biointerface property between the substrate and coating. The immersion tests showed that the hybrid coating considerably slowed down the degradation in the simulated body fluid (SBF) solution. In addition, in vitro electrochemical investigations confirmed that PCL/HA coating significantly improved corrosion resistance and greatly reduced corrosion rate by about 10 times compared to HA coating and about 900 times to untreated Mg–Zn–Ca sample. Moreover, cytotoxicity assessment exhibited PCL/HA hybrid coating enhanced biocompatibility and bioactivity due to adopting a suitable interfacial engineering approach.